Positives

• Long COVID patients who received MSC infusions at a Larnaca Cyprus clinic commonly note significant improvement 2-3 months post-therapy, particularly in post-COVID fatigue and neurological complications.
• In one Cayman Islands clinic’s preliminary cohort, 85% of patients reported symptom improvements within the first 3 months post-infusion.

Negatives

• Research specifically investigating MSC therapy for ME/CFS remains limited and preliminary, with findings that need further validation before strong claims can be made Science for ME.
  
  

Hurdles & Side Effects

• MSC therapy outside research settings is typically administered at private clinics in Mexico, Panama, the Bahamas, or Cyprus at a cost of $15,000-$50,000 per treatment course, with no FDA-approved MSC product for Long COVID or ME/CFS available domestically Stem Cell Medical Center.
  
  
• High costs, regulatory hurdles, and the lack of standardized protocols across clinics persist as barriers; patients should ask any clinic for cell-source documentation, dose-per-kg specs, and follow-up data before committing Solve M.E..